PT - JOURNAL ARTICLE AU - Yu, Dalang AU - Yang, Xiao AU - Tang, Bixia AU - Pan, Yi-Hsuan AU - Yang, Jianing AU - Zhu, Junwei AU - Duan, Guangya AU - Hao, Zi-Qian AU - Mu, Hailong AU - Dai, Long AU - Hu, Wangjie AU - Zhang, Mochen AU - Cui, Ying AU - Jin, Tong AU - Li, Cuiping AU - Ma, Lina AU - , AU - Su, Xiao AU - Zhang, Guo-Qing AU - Zhao, Wenming AU - Li, Haipeng TI - Coronavirus GenBrowser for monitoring the transmission and evolution of SARS-CoV-2 AID - 10.1101/2020.12.23.20248612 DP - 2021 Jan 01 TA - medRxiv PG - 2020.12.23.20248612 4099 - http://medrxiv.org/content/early/2021/02/10/2020.12.23.20248612.short 4100 - http://medrxiv.org/content/early/2021/02/10/2020.12.23.20248612.full AB - COVID-19 has widely spread across the world, and much research is being conducted on the causative virus SARS-CoV-2. To help control the infection, we developed the Coronavirus GenBrowser (CGB) to monitor the pandemic. With CGB, 178,765 high quality SARS-CoV-2 genomic sequences were analyzed, and 121,522 mutations were identified. In total, 1,041 mutation cold spots were found, suggesting that these spots are key functional elements of SARS-CoV-2 and can be used for detection and vaccine development. CGB revealed 203 accelerated evolutions of SARS-CoV-2, but variants with accelerated evolution were not found to be highly contagious, suggesting that most of these evolutions are neutral. The B.1.1.7 (CGB75056.84017) lineage previously identified in the UK was not found to be significantly accelerated although its adaptive evolution was detected. Moreover, 2,297 strains with a significantly reduced evolutionary rate were identified, including three closely related variants widely spreading in Europe with no mutations in three months. By lineage tracing, a strain dated early March 2020 was determined to be the most recent common ancestor of nine strains collected from six different regions in three continents. This strain was also found to cause the outbreak in Xinfadi, Beijing, China in June 2020. CGB allows visualization and analysis of hundreds of thousands of SARS-CoV-2 genomic sequences. Distributed genome alignments and its effective analysis pipeline ensure timely update of the latest genomic data of SARS-CoV-2. CGB is an efficient platform for the general public to monitor the transmission and evolution of SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from the National Key Research and Development Project (No. 2020YFC0847000).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the timely-updated data are freely available at https://bigd.big.ac.cn/ncov/apis/. The free desktop standalone version provides the full function of CGB and has a plug-in module for the eGPS software (http://www.egps-software.net/) 29. Although the web-based tool is a simplified version of CGB (Figure 4) (https://www.biosino.org/genbrowser/ and https://bigd.big.ac.cn/genbrowser/), it provides a convenient way to access the data via a web browser, such as Google Chrome, Firefox and Safari.